Novartis Investigative Site

Fair Lawn, New Jersey 07410

We've found

2 trials

at this facility

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Status: Enrolling, Phase
Updated: 12/31/1969

from

Fair Lawn, NJ

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Fair Lawn, NJ

Use our guide to learn which trials are right for you!